DRD2 and Anxiety: In another study systemic treatment with a novel antagonist targeting H3R/D2R/D3R receptors, called ST-2223, improved social deficits and reduced anxiety levels associated with ASD in male Black and Tan Brachyury (BTBR) mice [209,210].